ANX5; ENX2; PP4; PAP-I; CBP-I; Anchorin CII; Calphobindin I; Endonexin II; Lipocortin V; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha
FBA; ALDO-A; Fructose 1,6 Bisphosphate Aldolase; Lung cancer antigen NY-LU-1; Muscle-type aldolase
CD9; TSPAN29; 5H9; BA2; BTCC-1; DRAP-27; GIG2; MIC3; P24; Tetraspanin 29; Cell growth-inhibiting gene 2 protein; Leukocyte antigen MIC3
HLA-DRB1; MHCDRb1; HLADRb1; Major Histocompatibility Complex Class II DR Beta 1; HLA Class II Histocompatibility Antigen,DRB1-9 Beta Chain; HLA class II histocompatibility antigen, DRB1-15 beta chain
CD278; AILIM; Inducible T-Cell Costimulator; Activation-Inducible Lymphocyte Immunomediatory Molecule
CD16b; CD16-B; FCGR3-B; FCG3; FcgRIII; Low affinity immunoglobulin gamma Fc region receptor III-B
CD4mut; p55; T-cell surface glycoprotein CD4; T-cell surface antigen T4/Leu-3
CD71; TFR1; P90; TFRC; T9; Trfr; sTfR; Transferrin receptor protein 1, serum form
PTPRC; PTPR-C; LCA; B220; GP180; LY5; T200; Leukocyte common antigen
CD71; TFR1; P90; TFRC; T9; Trfr; sTfR; Transferrin receptor protein 1, serum form
MHC-C;; HLAC; HLA-JY3; HLC-C; HLA-C; PSORS1 Leukocyte Antigen C; HLA class I histocompatibility antigen, Cw-7 alpha chain